OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - EDWARDS LIFESCIENCES | Market Closed - Deutsche Boerse AG 20:43:13 30/05/2024 BST | ||
| 2.81 EUR | -2.77% |
|
| Current month | -10.22% | ||
| 1 month | -10.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 30/05/24 | 2.81 | -2.77% |
| 29/05/24 | 2.89 | +0.70% |
| 28/05/24 | 2.87 | +3.24% |
| 27/05/24 | 2.78 | -0.71% |
| 24/05/24 | 2.8 | -1.41% |
Delayed Quote Deutsche Boerse AG
Last update May 30, 2024 at 08:43 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV4HFP |
| ISIN | DE000SV4HFP6 |
| Date issued | 18/04/2023 |
| Strike | 118.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.93 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.37 € |
|---|---|
| Lowest since issue | 1.99 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
87.03
USD
Average target price
96.55
USD
Spread / Average Target
+10.94%
- Stock Market
- Certificates
- Certificat
